secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001213900-24-069021
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Movano Health Q2 2024 operating loss narrows to $6.4M; Evie Ring back in stock Sept 17
--------------------------------------------------------------------------------

- Operating loss of $6.4M improved from $7.4M in Q2 2023; no revenue reported as refunds offset deferred revenue.
- Shipped 1,837 Evie Rings in Q2; cash and equivalents $16.9M at June 30, 2024.
- Evie Ring expected back in stock September 17, 2024; brand partnership with Heidi D'Amelio announced.
- FDA live meeting scheduled mid-August for EvieMED 510(k) clearance; B2B opportunities with pharma and payor advancing.
- April 2024 $24.1M private placement closed with tier-1 medical device company investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024069021/0001213900-24-069021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024069021/ea0211408-8k_movano.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-069021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer